Genomics tools—fine-tuned and applied to agriculture—create commercially desirable traits in a fraction of the time required ...
Next-generation instruments improve rare-cell detection, sterility control, biosafety, and throughput for translational ...
A 1,563‑sample chromatin atlas reveals 16 epigenomic subgroups of AML, redefining disease classification, prognosis, and therapeutic vulnerabilities.
The STEM-PD research team will now continue the long-term follow-up of the participants to further evaluate safety, graft function, and clinical benefit.
The CRADA establishes a collaborative framework on medical countermeasures that protect global populations and U.S. soldiers ...
The FDA PreCheck Pilot Program will focus on manufacturing readiness, regulatory predictability, and expedited facility ...
Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals for $10 billion cash, in a deal that would expand the ...
Researchers have developed new AI approach to select chemical compounds potentially effective for treating tuburculosis.
Strategies are reshaping biologics manufacturing by boosting speed, flexibility, and productivity without expanding ...
Under the two-year project timeline, researchers will spend the first year optimizing vaccine candidates and evaluating their ...
New perfusion technologies and AI-driven controls are accelerating adoption across commercial biologics manufacturing.
By restoring the body’s ability to produce KLK1, therapies are emerging for preeclampsia moms and for acute ischemic stroke who missed the tPA window.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results